{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:11:52Z","timestamp":1793797912348,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jhep.2015.10.020","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T19:49:20Z","timestamp":1446234560000},"page":"691-698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":200,"title":["Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis"],"prefix":"10.1016","volume":"64","author":[{"given":"Denise","family":"Or\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetyana","family":"Yudina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Fern\u00e1ndez-Varo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eudald","family":"Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedrana","family":"Reichenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregori","family":"Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardino","family":"Gonz\u00e1lez de la Presa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sandalinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Puntes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wladimiro","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.10.020_b0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2015.10.020_b0010","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.10.020_b0015","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/ATVBAHA.110.213850","article-title":"Mechanisms of resolution of inflammation: a focus on cardiovascular disease","volume":"31","author":"Maskrey","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2015.10.020_b0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2015.10.020_b0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/IJN.S15308","article-title":"The protective effects of cerium oxide nanoparticles against hepatic oxidative damage induced by monocrotaline","volume":"6","author":"Amin","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.jhep.2015.10.020_b0030","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/smll.200901048","article-title":"Anti-inflammatory properties of cerium oxide nanoparticles","volume":"5","author":"Hirst","year":"2009","journal-title":"Small"},{"key":"10.1016\/j.jhep.2015.10.020_b0035","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.freeradbiomed.2011.06.006","article-title":"Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia","volume":"51","author":"Estevez","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2015.10.020_b0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.111.179978","article-title":"Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-\u03baB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract","volume":"338","author":"Niu","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2015.10.020_b0045","doi-asserted-by":"crossref","first-page":"10726","DOI":"10.1021\/nn403542p","article-title":"Absence of Ce3+ sites in chemically active colloidal ceria nanoparticles","volume":"7","author":"Cafun","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jhep.2015.10.020_b0050","doi-asserted-by":"crossref","first-page":"e47562","DOI":"10.1371\/journal.pone.0047562","article-title":"Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin","volume":"7","author":"Comenge","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.10.020_b0055","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/jn\/138.10.1866","article-title":"Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax","volume":"138","author":"Wang","year":"2008","journal-title":"J Nutr"},{"key":"10.1016\/j.jhep.2015.10.020_b0060","first-page":"126","article-title":"Cerium oxide nanoparticles: potential applications for cancer and other diseases","volume":"5","author":"Wason","year":"2013","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jhep.2015.10.020_b0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1039\/C4EN00138A","article-title":"Catalytic properties and biomedical applications of cerium oxide nanoparticles","volume":"2","author":"Walkey","year":"2015","journal-title":"Environ Sci Nano"},{"key":"10.1016\/j.jhep.2015.10.020_b0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jhep.2015.10.020_b0075","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.biomaterials.2008.03.014","article-title":"The role of cerium redox state in the SOD mimetic activity of nanoceria","volume":"29","author":"Heckert","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jhep.2015.10.020_b0080","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1021\/nn800511k","article-title":"Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties","volume":"2","author":"Xia","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/j.jhep.2015.10.020_b0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nnano.2006.91","article-title":"Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides","volume":"1","author":"Chen","year":"2006","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.jhep.2015.10.020_b0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cardiores.2006.11.031","article-title":"Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy","volume":"73","author":"Niu","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jhep.2015.10.020_b0095","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2147\/IJN.S25119","article-title":"Intratracheal instillation of cerium oxide nanoparticles induces hepatic toxicity in male Sprague-Dawley rats","volume":"6","author":"Nalabotu","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.jhep.2015.10.020_b0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.taap.2012.02.008","article-title":"Alteration of hepatic structure and oxidative stress induced by intravenous nanoceria","volume":"260","author":"Tseng","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2015.10.020_b0105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/toxsci\/kfs067","article-title":"Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats","volume":"127","author":"Yokel","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhep.2015.10.020_b0110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/hep.21080","article-title":"Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension","volume":"43","author":"Hern\u00e1ndez Guerra","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.020_b0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/gut.2008.149880","article-title":"Superoxide dismutase gene transfer reduces portal pressure in CCl4-treated rats with portal hypertension","volume":"58","author":"Lavi\u00f1a","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.10.020_b0120","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.10.020_b0125","doi-asserted-by":"crossref","first-page":"35715","DOI":"10.1074\/jbc.M006577200","article-title":"Peroxisome proliferator-activated receptors and hepatic stellate cell activation","volume":"275","author":"Miyahara","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.10.020_b0130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.plipres.2005.12.002","article-title":"From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions","volume":"45","author":"Feige","year":"2006","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jhep.2015.10.020_b0135","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0016-5085(00)70370-2","article-title":"An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis","volume":"118","author":"Cho","year":"2000","journal-title":"Gastroenterology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815007199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815007199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T04:27:09Z","timestamp":1567312029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815007199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0168827815007199"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.10.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}